Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Mol Cancer Ther ; 18(11): 1916-1925, 2019 11.
Article in English | MEDLINE | ID: mdl-31488700

ABSTRACT

RX-5902 is a first-in-class anticancer agent targeting phosphorylated-p68 and attenuating nuclear shuttling of ß-catenin. The purpose of this study was to evaluate the efficacy of RX-5902 in preclinical models of triple-negative breast cancer (TNBC) and to explore effects on ß-catenin expression. A panel of 18 TNBC cell lines was exposed to RX-5902, and changes in proliferation, apoptosis, cellular ploidy, and effector protein expression were assessed. Gene expression profiling was used in sensitive and resistant cell lines with pathway analysis to explore pathways associated with sensitivity to RX-5902. The activity of RX-5902 was confirmed in vivo in cell line and patient-derived tumor xenograft (PDX) models. RX-5902 demonstrated potent antiproliferative activity in vitro against TNBC cell lines with an average IC50 of 56 nmol/L in sensitive cell lines. RX-5902 treatment resulted in the induction of apoptosis, G2-M cell-cycle arrest, and aneuploidy in a subset of cell lines. RX-5902 was active in vivo against TNBC PDX models, and treatment resulted in a decrease in nuclear ß-catenin. RX-5902 exhibited dose-proportional pharmacokinetics and plasma and tumor tissue in nude mice. Pathway analysis demonstrated an increase in the epithelial-to-mesenchymal transformation (EMT), TGFß, and Wnt/ß-catenin pathways associated with sensitivity to RX-5902. RX-5902 is active against in vitro and in vivo preclinical models of TNBC. Target engagement was confirmed with decreases in nuclear ß-catenin and MCL-1 observed, confirming the proposed mechanism of action. This study supports the continued investigation of RX-5902 in TNBC and combinations with immunotherapy.


Subject(s)
Antineoplastic Agents/administration & dosage , Piperazines/administration & dosage , Quinoxalines/administration & dosage , Triple Negative Breast Neoplasms/drug therapy , Wnt Signaling Pathway/drug effects , eIF-2 Kinase/metabolism , Animals , Antineoplastic Agents/pharmacology , Cell Line, Tumor , Cell Proliferation/drug effects , Cell Survival/drug effects , Female , Gene Expression Regulation, Neoplastic/drug effects , Humans , Mice , Myeloid Cell Leukemia Sequence 1 Protein/metabolism , Phosphorylation , Piperazines/pharmacology , Quinoxalines/pharmacology , Triple Negative Breast Neoplasms/metabolism , Xenograft Model Antitumor Assays , beta Catenin/metabolism
2.
PLoS One ; 7(5): e36459, 2012.
Article in English | MEDLINE | ID: mdl-22570717

ABSTRACT

GABAergic pathways in the brainstem play an essential role in respiratory rhythmogenesis and interactions between the respiratory and cardiovascular neuronal control networks. However, little is known about the identity and function of these GABAergic inhibitory neurons and what determines their activity. In this study we have identified a population of GABAergic neurons in the ventrolateral medulla that receive increased excitatory post-synaptic potentials during inspiration, but also have spontaneous firing in the absence of synaptic input. Using transgenic mice that express GFP under the control of the Gad1 (GAD67) gene promoter, we determined that this population of GABAergic neurons is in close apposition to cardioinhibitory parasympathetic cardiac neurons in the nucleus ambiguus (NA). These neurons fire in synchronization with inspiratory activity. Although they receive excitatory glutamatergic synaptic inputs during inspiration, this excitatory neurotransmission was not altered by blocking nicotinic receptors, and many of these GABAergic neurons continue to fire after synaptic blockade. The spontaneous firing in these GABAergic neurons was not altered by the voltage-gated calcium channel blocker cadmium chloride that blocks both neurotransmission to these neurons and voltage-gated Ca(2+) currents, but spontaneous firing was diminished by riluzole, demonstrating a role of persistent sodium channels in the spontaneous firing in these cardiorespiratory GABAergic neurons that possess a pacemaker phenotype. The spontaneously firing GABAergic neurons identified in this study that increase their activity during inspiration would support respiratory rhythm generation if they acted primarily to inhibit post-inspiratory neurons and thereby release inspiration neurons to increase their activity. This population of inspiratory-modulated GABAergic neurons could also play a role in inhibiting neurons that are most active during expiration and provide a framework for respiratory sinus arrhythmia as there is an increase in heart rate during inspiration that occurs via inhibition of premotor parasympathetic cardioinhibitory neurons in the NA during inspiration.


Subject(s)
Brain Stem/metabolism , GABAergic Neurons/metabolism , Synaptic Transmission/physiology , Animals , Brain Stem/drug effects , GABA Antagonists/pharmacology , GABAergic Neurons/drug effects , Mice , Mice, Transgenic , Neurons/drug effects , Neurons/metabolism , Respiration/drug effects , Sodium Channel Blockers/pharmacology , Synaptic Transmission/drug effects
3.
Exp Neurol ; 207(2): 248-57, 2007 Oct.
Article in English | MEDLINE | ID: mdl-17689532

ABSTRACT

We compared the binding profiles of medications potentially useful in the treatment of involuntary emotional expression disorder at twenty-six binding sites in rat brain tissue membranes. Sites were chosen based on likelihood of being target sites for the mechanism of action of the agents in treating the disorder or their likelihood in producing side effects experienced by patients treated with psychoactive agents. We used radioligand binding assays employing the most selective labeled ligands available for sites of interest. Concentrations of labeled ligand were used at or below the K(i) value of the ligand for the target site. Compounds were initially screened at 1 muM. For compounds that competed for greater than 20-30% of specific binding at target sites of interest, full concentration curves were constructed. Dextromethorphan, amitriptyline and fluoxetine competed for binding to sigma(1) receptors and to serotonin transporters with high to moderate affinity. Of the target sites tested, these are the most likely to contribute to the therapeutic benefit of the various agents. In addition, all three drugs showed some activity at alpha(2) and 5-HT(1B/D) sites. Of the drugs tested, dextromethorphan bound to the fewest sites unlikely to be target sites. Although the mechanism of action of dextromethorphan or any drug that has been used in the treatment of involuntary emotional expression disorder is currently unknown, our data support that the affinity of the drug for sigma(1) receptors is consistent with its possible action through this receptor type in controlling symptoms of the disorder.


Subject(s)
Affective Symptoms/metabolism , Amitriptyline/pharmacokinetics , Antidepressive Agents/pharmacokinetics , Binding, Competitive/drug effects , Excitatory Amino Acid Antagonists/pharmacokinetics , Fluoxetine/pharmacokinetics , Memantine/pharmacokinetics , Animals , Binding Sites/drug effects , Brain/cytology , Brain/drug effects , Dextromethorphan/pharmacokinetics , Dose-Response Relationship, Drug , Male , Membranes/drug effects , Radioligand Assay/methods , Rats , Receptors, Neurotransmitter/drug effects
4.
Synapse ; 59(6): 342-9, 2006 May.
Article in English | MEDLINE | ID: mdl-16463401

ABSTRACT

We investigated the effect of in vitro exposure to nicotinic acetylcholine receptors (nAChRs), agonists, antagonists, and protein kinase A (PKA) modulators on the activity of the serotonin transporter (SERT) in prefrontocortical (PFC) synaptosomes. The plasma membrane SERT is an active transport mechanism specific for serotonin. Receptors and second messengers capable of altering transporter activity would be expected to have profound effects on serotonergic neurotransmission and on functions involving serotonergic input, such as cognition, anxiety, and mood. Our data suggest that activation of nAChRs, quite likely via PKA, increase the activity of the SERT in the PFC and, thereby, can alter 5-HT levels in a region important in the behavioral effects of nicotine and 5-HT. Nicotine at 4 microM increased [(3)H]5-HT uptake by 75%. Because the nAChR antagonists mecamylamine and dihydro-beta-erythrodine (DHbetaE) both decreased [(3)H]5-HT uptake into synaptosomes, it appeared that the SERT might be tonically activated by acetylcholine present within our synaptosomal preparations. Blocking PKA significantly decreased [(3)H]5-HT, while stimulation of PKA activity significantly increased the uptake. A 66% decrease compared with control was produced by 100 microM Rp-cAMP, and a 41% increase in 5-HT uptake over control was observed with 30 microM Sp-cAMPs. Furthermore, the enhancement in uptake produced by 4 microM nicotine was inhibited in a time-dependent fashion by preincubation with 10 microM Rp-cAMP. A better understanding of the influence of the cholinergic system and the receptors involved in the trafficking of SERT would help clarify the important relationship between the cholinergic and serotonergic systems and the role these systems play in behavior.


Subject(s)
Cyclic AMP-Dependent Protein Kinases/physiology , Prefrontal Cortex/metabolism , Receptors, Nicotinic/physiology , Serotonin Plasma Membrane Transport Proteins/metabolism , Animals , Atropine/pharmacology , Carbachol/pharmacology , Cholinergic Agonists/pharmacology , Cyclic AMP/analogs & derivatives , Cyclic AMP/pharmacology , Dihydro-beta-Erythroidine/pharmacology , Dose-Response Relationship, Drug , Drug Interactions , In Vitro Techniques , Mecamylamine/pharmacology , Muscarinic Antagonists/pharmacology , Nicotine/pharmacology , Nicotinic Agonists/pharmacology , Nicotinic Antagonists/pharmacology , Prefrontal Cortex/cytology , Prefrontal Cortex/drug effects , Protein Kinase Inhibitors/pharmacology , Rats , Serotonin/metabolism , Serotonin/pharmacokinetics , Synaptosomes/drug effects , Thionucleotides/pharmacology , Time Factors , Tritium/pharmacokinetics
5.
Dev Psychobiol ; 48(1): 79-94, 2006 Jan.
Article in English | MEDLINE | ID: mdl-16381028

ABSTRACT

The current study established a procedure to evaluate the capability of rats on postnatal days (PND) 21, 26, and 30 to perform a spatial serial reversal task using a T-maze. Training consisted of an acquisition session followed by a series of six reversal sessions. To examine the role of proactive interference in the serial reversal effect, the point of reversal was manipulated so that it occurred at the start of each session (between-sessions) or the midpoint of each session (within-sessions). Performance was initially impaired during the first reversal but improved dramatically across the series. Reversal between-sessions enhanced this serial reversal effect in comparison to reversal within-sessions. Experiment 1 showed that rats of all ages learned the between-sessions serial reversal task at a comparable rate. However, on the within-sessions task, PND21 rats were impaired relative to the PND26 and 30 rats, which did not differ. Experiment 2 revealed that the addition of a tactile cue that is correlated with each phase of reversal eliminated age and task differences in serial reversal performance. These findings suggest that higher-order cognitive processes underlying serial reversal are present during the weanling period, but there is some improvement with age under conditions involving high memory interference and/or difficulty in detecting the transition between reversal phases.


Subject(s)
Discrimination, Psychological , Maze Learning/physiology , Space Perception , Spatial Behavior , Age Factors , Animals , Animals, Newborn , Female , Male , Memory , Rats
SELECTION OF CITATIONS
SEARCH DETAIL
...